$REVB
Revelation Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.836
▲+11.19%+$0.084
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRevelation Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is REVB up today? It is at $0.836 (+11.19%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment REVB spikes, and full due diligence on REVB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $REVB 1 time in the last 30 days. Create a free account to track $REVB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on REVB from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carver Jennifer Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 45K | n/a | Aug 17, 26 |
Roper Jess Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 45K | n/a | Aug 17, 26 |
Rolke James Officer | Acquired (grant/award) | +208K 5.2% of company | added 97% | 423K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Acquired (grant/award) | +208K 5.2% of company | n/a | 208K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -208K 5.2% of company | n/a | n/a | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Acquired (grant/award) | +208K 5.2% of company | added 100% | 300K | n/a | Aug 17, 26 |
Chawla Lakhmir S Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 44K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -13K 0.3% of company | sold 13% | 92K | $15K at $1.10 | Apr 30, 26 |
Rolke James Officer | Sold (automatic/other) | -10K 0.3% of company | sold 4.5% | 215K | $11K at $1.13 | Apr 30, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -13K 0.3% of company | sold 11% | 105K | $22K at $1.65 | Feb 4, 26 |
Rolke James Officer | Sold (automatic/other) | -9K 0.2% of company | sold 3.7% | 225K | $16K at $1.86 | Feb 3, 26 |
Carver Jennifer Director | Sold (automatic/other) | -2K 0.04% of company | sold 12% | 13K | $3K at $1.87 | Feb 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on REVB from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
REVB last traded at $0.836, up 11.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The REVB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged REVB 1 time in the last 30 days.
REVB (Revelation Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $3M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge REVB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$REVB discussion
Sign in to ask a question or join the discussion.